Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program - Tandstad, T; Dahl, O; Cohn-Cedermark, G (J Clin Oncol, 2009)
et al.